| Identification | Back Directory | [Name]
CPX 351 | [CAS]
1256639-86-7 | [Synonyms]
CPX351
Vyxeos
CPX 351
CPX-351
Cytarabine/daunonubicin
Daunonubicin/cytarabine |
| Hazard Information | Back Directory | [Description]
CPX-351 is a Liposomal-encapsulated combination of daunorubicin and cytarabine for the treatment of newly diagnosed tAML or AML with myelodysplasia-related changes (AML-MRCs). |
|
|